Post-earnings recap
Reported
Wed, Jul 29, 2026
EPS actual
$0.15
EPS est.
$0.16
EPS surprise
-7.98%
1-day move
-2.47%
Bausch + Lomb's earnings report showed a miss on EPS, which contributed to a 2.47% decline in stock price. The lack of revenue information and management commentary leaves investors with limited insights into the company's performance and future outlook.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.15 | N/A | -7.98% |
| Revenue | N/A | N/A | N/A |
No transcript is on record, and the analysis is based on numerical results only.
Bausch + Lomb Corporation (BLCO) is a health care company focused on eye health products, including contact lenses and surgical devices. With a market cap of $6 billion, it plays a critical role in the growing health care supplies sector, addressing the increasing demand for vision care solutions.
Last quarter
In Q1-2026, Bausch + Lomb reported an EPS of $0.05, missing the estimate of $0.06, which led to a 2.42% drop in stock price the following day. The company continues to face challenges in meeting earnings expectations.
EPS beat streak
0Q
EPS beat rate
38%
Avg EPS surprise
-76.66%
Avg 1-day reaction
-3.43%
Overall, investors are cautious about Bausch + Lomb's upcoming earnings, especially given the recent earnings misses. The lack of analyst estimates adds uncertainty to market expectations.
Bull case
If Bausch + Lomb can surprise with better-than-expected EPS and revenue growth, it could signal a turnaround and renewed investor confidence.
Bear case
Continued earnings misses or weak guidance could lead to further declines in stock price, reflecting ongoing operational challenges.
The print will turn on these.
Q1
What will the EPS be this quarter, and how does it compare to analyst expectations?
Given the company's recent history of missing EPS estimates, this figure will be crucial in assessing management's performance and future outlook.
Q2
What guidance will management provide for revenue growth in the upcoming quarters?
Clear guidance on revenue growth will help investors understand the company's strategy and ability to capture market demand.
—
Est. EPS
—
Est. Rev
—
Impl. Move
±3.5%
Why consensus could be wrong
The Street may underestimate Bausch + Lomb's potential for recovery, given its recent investments in product innovation and market expansion.
Supporting evidence
Despite recent earnings misses, the company has a strong product pipeline that could drive future growth.
Options pricing suggests a significant move, indicating that investors are bracing for a potential surprise.
The company's historical performance shows it can rebound after earnings misses, as seen in previous quarters.
Key risk
If the EPS exceeds $0.10, it could challenge the current negative sentiment and shift investor expectations.
Pre-commit to what would confirm each case.
This quarter's results are pivotal as they will either validate the company's recovery strategy or highlight ongoing challenges.
Bull confirmed if
An EPS of $0.10 or higher would confirm a positive outlook and suggest operational improvements.
Bear confirmed if
An EPS below $0.05 would reinforce concerns about the company's ability to meet market expectations.
What the market is pricing for the move.
Implied Move
±8.1%
Historical Avg
±3.9%
The options market is pricing in a significant move of about 8.1% in either direction, indicating heightened uncertainty around the earnings report.
Options are pricing ±8.1% while BLCO has averaged ±3.9% over the last 8 prints — setup is pricing rich.
ATM IV
0.4%
30d HV
23.7%
Smart-money positioning from the most recent 13F filings.
Institutional
11.14%
of float
Insider
87.29%
of float
Holders
123
institutions
Top Holders· as of Jun 2026
Icahn Carl C
3,500,000 sh · $60.7M
0.98%
Flat
Likely market behavior by outcome. Not investment advice.
Beat & raise
If Bausch + Lomb beats expectations, history suggests a modest positive reaction, potentially confirming a turnaround in performance.
In line / cautious
If results are in line with expectations, the stock may react cautiously, reflecting ongoing uncertainty in management's guidance.
Miss
If the company misses again, history suggests a larger decline, as investors may lose confidence in the company's ability to execute.
The lines on the call that would change the story.
Deutsche Bank AG
3,423,046 sh · $59.4M
0.96%
-3.0%
Oaktree Capital Management LP
3,441,042 sh · $59.7M
0.96%
1.7%
Shaw D.E. & Co., Inc.
3,323,021 sh · $57.6M
0.93%
5.5%
Davidson Kempner Capital Management LP
3,158,972 sh · $54.8M
0.88%
43.6%
13F filings updated quarterly. Position deltas show change in shares vs. the prior quarter.